News
URPL: Information of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of February 16, 2015 on the support which European experts will provide in the context of the global response to the growing epidemi
17.02.2016
This document is announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of February 16, 2015 on the support which European experts
...
URPL: Information of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of February 16, 2015 on on the malfunctioning analyzer INR used in the study ROCKET
17.02.2016
This document is announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of February 16, 2015 on on the malfunctioning analyzer INR
...
EMA: Draft concept paper on guidance on statistical principles for clinical trials for immunological veterinary medicinal products
29.01.2016
A guideline on statistical principles for veterinary clinical trials for veterinary medicinal products (pharmaceuticals) (EMA/CVMP/EWP/81976/2010) was adopted in 2012. This guideline provides
...
EMA: First specific replacement therapy to treat rare bleeding disorder
29.01.2016
Coagadex recommended for approval for prevention of bleeding episodes for patients with factor X deficiency
The European Medicines Agency (EMA) has recommended granting a marketing authorisation
...
RAPS: FDA Approves First Drug to Improve Overall Survival in Liposarcoma
29.01.2016
FDA Approves First Drug to Improve Overall Survival in Liposarcoma
The US Food and Drug Administration (FDA) on Thursday approved a new indication for Eisai\'s Halaven (eribulin mesylate) to
...
RAPS: CFDA Begins Overseas Inspections
29.01.2016
CFDA Warns Indian, Japanese Manufacturers as Overseas Inspection Drive Begins
China Food and Drug Administration (CFDA) has found fault with the manufacturing practices of four foreign
...
URPL: Information of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of January 12, 2015 concerning the consequences of the loss of news tips published in the European Commission document,, Manual of D
29.01.2016
This document is announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of January 12, 2015 concerning the consequences of the loss
...
FDA: Use of Nucleic Acid Tests to Reduce the Risk of Transmission of Hepatitis B Virus from Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products
11.01.2016
We, FDA, are providing you, establishments that make donor eligibility determinations for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps), with recommendations
...
FDA: Safety Assessment for IND Safety Reporting
11.01.2016
This document provides guidance to sponsors on developing a systematic approach for investigational new drug application (IND) safety reporting for human drugs and biological products2 developed
...
FDA: Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products
11.01.2016
This guidance document provides you, blood establishments that collect blood or blood components, including Source Plasma, with FDA’s revised donor deferral recommendations for individuals with
...